Korea Investment Corp Novavax Inc Transaction History

Korea Investment Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $151,469 - $314,335	4,175 Added 596.43%	4,875 $251,000
Q1 2022 May 13, 2022	SELL	$69.73 - $142.9 $955,301 - $1.96 Million	-13,700 Reduced 95.14%	700 $52,000
Q4 2021 Feb 09, 2022	SELL	$134.56 - $217.97 $13,456 - $21,797	-100 Reduced 0.69%	14,400 $2.06 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $195,580 - $297,638	1,100 Added 8.21%	14,500 $3.01 Million
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $1.62 Million - $3.45 Million	13,400 New	13,400 $2.85 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Korea Investment Corp, based on Form 13F filings with the SEC.

Stay updated on Korea Investment Corp with notifications on news.